Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Goodwill & Intangibles (2024 - 2025)

Mangoceuticals (MGRX) has disclosed Goodwill & Intangibles for 2 consecutive years, with $14.2 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 6.57% to $14.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.2 million through Dec 2025, down 6.57% year-over-year, with the annual reading at $14.2 million for FY2025, 6.57% down from the prior year.
  • Goodwill & Intangibles hit $14.2 million in Q4 2025 for Mangoceuticals, down from $15.9 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $21.5 million in Q1 2025 to a low of $14.2 million in Q4 2025.